Labeler
AvKARE NDC Codes
AvKARE lists 361 finished drug products in the FDA NDC Directory under NDC labeler codes 42291, 73190.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dasatinib, Risperidone, Lisdexamfetamine Dimesylate, brivaracetam, Eltrombopag Olamine, Deflazacort, Tapentadol Hydrochloride, Tofacitinib, Famciclovir, olmesartan medoxomil-hydrochlorothiazide, Sacubitril and Valsartan, Captopril, Diltiazem Hydrochloride Extended-Release, nintedanib, roflumilast
- Active ingredients
- Dasatinib, Risperidone, Lisdexamfetamine dimesylate, Brivaracetam, Eltrombopag olamine, Deflazacort, Tapentadol hydrochloride, Tofacitinib citrate, Famciclovir, Olmesartan medoxomil, Hydrochlorothiazide, Sacubitril
- NDC labeler codes
- 42291, 73190
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Tapentadol hydrochloride 50 mg/1; Tapentadol hydrochloride 75 mg/1; Tapentadol hydrochloride 100 mg/1; Lacosamide 10 mg/mL; Deferiprone 500 mg/1; Tofacitinib citrate 5 mg/1; Tofacitinib citrate 10 mg/1; Famciclovir 125 mg/1; Famciclovir 250 mg/1; Famciclovir 500 mg/1; Nintedanib esylate 100 mg/1; Nintedanib esylate 150 mg/1; Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 25 mg/1; Roflumilast 250 ug/1; Roflumilast 500 ug/1; Tofacitinib citrate 11 mg/1; Amantadine hydrochloride 100 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Capsule, Extended release, Tablet, Orally disintegrating, Solution, Tablet, Film coated, Extended release, Suspension, Tablet, Extended release
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor, Angiotensin 2 Receptor Blocker, Atypical Antipsychotic, Central Nervous System Stimulant, Thrombopoietin Receptor Agonist, Corticosteroid, Serotonin-3 Receptor Antagonist, Opioid Agonist, Janus Kinase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Thiazide Diuretic, Neprilysin Inhibitor, Angiotensin Converting Enzyme Inhibitor, Calcium Channel Blocker, Iron Chelator, Phosphodiesterase 4 Inhibitor, Thyroid Hormone Synthesis Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor, Cephalosporin Antibacterial, Serotonin Reuptake Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Progesterone, Phosphate Binder, P2Y12 Platelet Inhibitor, Serotonin-1b and Serotonin-1d Receptor Agonist, Phosphodiesterase 5 Inhibitor, Serotonin-4 Receptor Agonist, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Antimetabolite Immunosuppressant, Influenza A M2 Protein Inhibitor, Antimalarial, Antiprotozoal, Muscle Relaxant, Sulfone, alpha-Adrenergic Blocker, Tetracycline-class Drug, Osmotic Laxative, Potassium Salt, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Blood Coagulation Factor, Cholinergic Muscarinic Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 118 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| propranolol hydrochloride | Propranolol hydrochloride 160 mg/1 | Capsule, Extended releaseOral | 42291-525 | 42291-0525-0142291-0525-10 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 42291-560 | 42291-0560-90 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 42291-561 | 42291-0561-90 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 42291-562 | 42291-0562-90 | — |
| Aspirin and Extended-Release Dipyridamole | Aspirin 25 mg/1; Dipyridamole 200 mg/1 | CapsuleOral | 42291-116 | 42291-0116-60 | — |
| Torsemide | Torsemide 5 mg/1 | TabletOral | 42291-816 | 42291-0816-90 | — |
| Torsemide | Torsemide 10 mg/1 | TabletOral | 42291-817 | 42291-0817-90 | — |
| Torsemide | Torsemide 20 mg/1 | TabletOral | 42291-818 | 42291-0818-0142291-0818-5042291-0818-90 | — |
| Yuvafemestradiol | Estradiol 10 ug/1 | TabletVaginal | 42291-962 | 42291-0962-0842291-0962-18 | — |
| Oxybutynin Chloride Extended Releaseoxybutynin chloride | Oxybutynin chloride 5 mg/1 | Tablet, Extended releaseOral | 42291-633 | 42291-0633-0142291-0633-50 | — |
| Oxybutynin Chloride Extended Releaseoxybutynin chloride | Oxybutynin chloride 10 mg/1 | Tablet, Extended releaseOral | 42291-634 | 42291-0634-0142291-0634-50 | — |
| Oxybutynin Chloride Extended Releaseoxybutynin chloride | Oxybutynin chloride 15 mg/1 | Tablet, Extended releaseOral | 42291-635 | 42291-0635-01 | — |
| Sulfamethoxazole and Trimethoprim | Sulfamethoxazole 400 mg/1; Trimethoprim 80 mg/1 | TabletOral | 42291-758 | 42291-0758-0142291-0758-50 | — |
| Sulfamethoxazole and Trimethoprim | Sulfamethoxazole 800 mg/1; Trimethoprim 160 mg/1 | TabletOral | 42291-759 | 42291-0759-0142291-0759-50 | — |
| Ergocalciferol | Ergocalciferol 1.25 mg/1 | Capsule, Liquid filledOral | 42291-266 | 42291-0266-01 | — |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | 42291-258 | 42291-0258-10 | — |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | 42291-259 | 42291-0259-01 | — |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | 42291-260 | 42291-0260-01 | — |
| Naltrexone Hydrochloride | Naltrexone hydrochloride 50 mg/1 | Tablet, Film coatedOral | 42291-632 | 42291-0632-3042291-0632-60 | — |
| Letrozole | Letrozole 2.5 mg/1 | Tablet, Film coatedOral | 42291-374 | 42291-0374-3042291-0374-90 | — |
| Torsemide | Torsemide 100 mg/1 | TabletOral | 42291-819 | 42291-0819-90 | — |
| Butalbital, Acetaminophen, and Caffeine | Butalbital 50 mg/1 + 2 more ingredients | CapsuleOral | 42291-181 | 42291-0181-01 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | 42291-594 | 42291-0594-01 | — |
| Metoclopramide | Metoclopramide hydrochloride 10 mg/1 | TabletOral | 42291-596 | 42291-0596-90 | — |
| Tizanidine Hydrochloride | Tizanidine hydrochloride 4 mg/1 | Capsule, Gelatin coatedOral | 42291-811 | 42291-0811-15 | — |
| Olanzapine and Fluoxetine | Olanzapine 3 mg/1; Fluoxetine hydrochloride 25 mg/1 | CapsuleOral | 42291-652 | 42291-0652-30 | — |
| Olanzapine and Fluoxetine | Olanzapine 6 mg/1; Fluoxetine hydrochloride 25 mg/1 | CapsuleOral | 42291-653 | 42291-0653-30 | — |
| Olanzapine and Fluoxetine | Olanzapine 6 mg/1; Fluoxetine hydrochloride 50 mg/1 | CapsuleOral | 42291-654 | 42291-0654-30 | — |
| Olanzapine and Fluoxetine | Olanzapine 12 mg/1; Fluoxetine hydrochloride 25 mg/1 | CapsuleOral | 42291-655 | 42291-0655-30 | — |
| Olanzapine and Fluoxetine | Olanzapine 12 mg/1; Fluoxetine hydrochloride 50 mg/1 | CapsuleOral | 42291-656 | 42291-0656-30 | — |
| Nystatin | Nystatin 500000 [USP'U]/1 | Tablet, Film coatedOral | 42291-651 | 42291-0651-90 | — |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 2 mg/1 | Tablet, Film coated, Extended releaseOral | 42291-713 | 42291-0713-30 | — |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 4 mg/1 | Tablet, Film coated, Extended releaseOral | 42291-714 | 42291-0714-30 | — |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 6 mg/1 | Tablet, Film coated, Extended releaseOral | 42291-715 | 42291-0715-30 | — |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 8 mg/1 | Tablet, Film coated, Extended releaseOral | 42291-716 | 42291-0716-30 | — |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 12 mg/1 | Tablet, Film coated, Extended releaseOral | 42291-717 | 42291-0717-30 | — |
| Amantadine HClamantadine hydrochloride | Amantadine hydrochloride 100 mg/1 | Capsule, Liquid filledOral | 42291-125 | 42291-0125-50 | — |
| Minoxidil | Minoxidil 2.5 mg/1 | TabletOral | 42291-618 | 42291-0618-01 | — |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | 42291-321 | 42291-0321-01 | — |
| Venlafaxine Hydrochloride | Venlafaxine hydrochloride 37.5 mg/1 | Capsule, Extended releaseOral | 42291-897 | 42291-0897-3042291-0897-5042291-0897-90 | — |
| Venlafaxine Hydrochloride | Venlafaxine hydrochloride 75 mg/1 | Capsule, Extended releaseOral | 42291-898 | 42291-0898-3042291-0898-5042291-0898-90 | — |
| Venlafaxine Hydrochloride | Venlafaxine hydrochloride 150 mg/1 | Capsule, Extended releaseOral | 42291-899 | 42291-0899-3042291-0899-5042291-0899-90 | — |
| Mexiletine Hydrochloride | Mexiletine hydrochloride 150 mg/1 | CapsuleOral | 42291-624 | 42291-0624-01 | — |
| Mexiletine Hydrochloride | Mexiletine hydrochloride 200 mg/1 | CapsuleOral | 42291-625 | 42291-0625-01 | — |
| Mexiletine Hydrochloride | Mexiletine hydrochloride 250 mg/1 | CapsuleOral | 42291-626 | 42291-0626-01 | — |
| Glipizide and Metformin Hydrochloride | Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 42291-305 | 42291-0305-01 | — |
| Glipizide and Metformin Hydrochloride | Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 42291-306 | 42291-0306-01 | — |
| Norethindrone Acetatenorethindrone | Norethindrone acetate 5 mg/1 | TabletOral | 42291-650 | 42291-0650-90 | — |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | 42291-366 | 42291-0366-0142291-0366-10 | — |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | 42291-367 | 42291-0367-0142291-0367-10 | — |
AvKARE: common questions
- What is AvKARE's NDC labeler code?
- 42291, 73190. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for AvKARE?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.